Mitochondrial Targeted Therapies to Prevent Maternal Diabetes-Induced Congenital Heart Defects
- PMID: 38559633
- PMCID: PMC10978448
- DOI: 10.1016/j.jacbts.2024.01.016
Mitochondrial Targeted Therapies to Prevent Maternal Diabetes-Induced Congenital Heart Defects
Keywords: congenital heart defects; fusion; maternal diabetes; mitochondria.
Conflict of interest statement
Dr Reddy is supported by an Additional Ventures Foundation grant, a Maternal Child Health Research Institute Faculty Scholar Award, and National Heart, Lung, and Blood Institute grant 1 R01 HL165245.
Comment on
- doi: 10.1016/j.jacbts.2023.11.008
Similar articles
-
Type 2 diabetes mellitus induces congenital heart defects in murine embryos by increasing oxidative stress, endoplasmic reticulum stress, and apoptosis.Am J Obstet Gynecol. 2016 Sep;215(3):366.e1-366.e10. doi: 10.1016/j.ajog.2016.03.036. Epub 2016 Mar 31. Am J Obstet Gynecol. 2016. PMID: 27038779 Free PMC article.
-
Pregestational Diabetes and Congenital Heart Defects.Rev Bras Ginecol Obstet. 2022 Oct;44(10):953-961. doi: 10.1055/s-0042-1755458. Epub 2022 Nov 29. Rev Bras Ginecol Obstet. 2022. PMID: 36446562 Free PMC article. Review.
-
Association of certain chronic maternal diseases with the risk of specific congenital heart defects: a population-based study.Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:1-6. doi: 10.1016/j.ejogrb.2014.08.022. Epub 2014 Aug 27. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 25216447
-
Effect of maternal pregestational diabetes mellitus on congenital heart diseases.World J Pediatr. 2023 Apr;19(4):303-314. doi: 10.1007/s12519-022-00582-w. Epub 2022 Jul 15. World J Pediatr. 2023. PMID: 35838899 Review.
-
Maternal Diabetes, Birth Weight, and Neonatal Risk of Congenital Heart Defects in Norway, 1994-2009.Obstet Gynecol. 2016 Nov;128(5):1116-1125. doi: 10.1097/AOG.0000000000001694. Obstet Gynecol. 2016. PMID: 27741197
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources